Program Introduction
In view of the potential health gains and the relative affordability of botanical and herbal medicines, and in the interest of sustainable health development for the world's population, particularly the poor in developing countries, CEPH, under the Directorship of Dr Max Reynolds, has established the Australasia Botanical Medicine for Population Health Program to pursue and promote international collaborations in research and development of herbal medicine for global health.
ABMPH's current focus on Melalecua Alternifolia Concentrate: Aiming at the exploration of efficacy of a range of traditional herbal medicine, the ABMPH's initial focus is on developing International Collaboration on Research Development on the efficacy and potential applications of MAC for the Treatment of Dengue Fever and a Range of Population Health Issues.
MAC is an Australian plant extract, with demonstrated safety for human consumption, is potentially the answer for a range of human and animal health issues caused by antibiotic resistant and shielded virus. Preliminary studies have shown promising results. However, much research, in addition to clinical trials, is required to examine and verify its efficacy and mechanism for disease treatment before it can be used to serve population health needs.
Dengue fever in particular, is recognised as a serious threat to the world's population as there is not yet a proven effective treatment. WHO and scientists around the world estimated that around 3 billion people globally will be at risk from Dengue fever due to climate change, urbanization, and world trade.
The aims of MAC Program are to: share information and knowledge on research and development in the application of MAC for dengue fever; discuss potential research development in the application of MAC on a range of health issues; explore and facilitate project development for future international collaborations.
Research partners
CEPH hosted an International Forum in 2007 to invite potential partners to attend. Partnership has since been established to collaborate on research and academic exchanges between Griffith U and University of Indonesia, Gadjah Mada University, Peking University, Cheng Kung University, and Sun Yat-sen University.
Current International Research Partners
- Australia
- Dr Rachel Thompson Greenslopes Hospital Brisbane (Thoracic Treatment Regime)
- Dr Steve Ralph Griffith Medical School (Cancer Research)
- Dr Anthony Carroll Griffith School of Environment (Structural Organic Chemistry)
- USA
-
- Dr Austin Brewin Avian Influenza (FDA Expert)
Collaboration on Disease Prevention and Treatment applying MAC
- What is MAC? (PDF 501k)
- Discoverer of MAC - Dr Maxwell Reynolds information (PDF 74k)
- Collaboration on disease prevention and treatment applying MAC representitives (PDF 215k)
Prof Max Reynolds visits CHC in Indonesia to discuss clinical trial collaborations on Dengue Fever
Prof Max Reynolds signs MOU with Prof Ian O'Conner, witnessed by Prof Cordia Chu, about the collaboration of MAC research with Griffith University